Stryker Corporation (SYK) was Reiterated by RBC Capital Mkts to “Outperform” according to the research note released today. The brokerage firm has raised the Price Target to $ 135 from a previous price target of $129 . RBC Capital Mkts advised their Clients and Investors in a research report released on Mar 3, 2017.
Based on several research reports , Company shares were Reiterated by RBC Capital Mkts on Mar 3, 2017 to “Outperform”, Firm has raised the Price Target to $ 135 from a previous price target of $129 .Company shares were Reiterated by RBC Capital Mkts on Mar 3, 2017 to “Outperform”, Firm has raised the Price Target to $ 135 from a previous price target of $129 .Company shares were Reiterated by Canaccord Genuity on Jan 25, 2017 to “Buy”, Firm has raised the Price Target to $ 137 from a previous price target of $127 .Stryker Corporation was Downgraded by Needham to ” Underperform” on Jan 6, 2017.
On the company’s financial health, Stryker Corporation reported $1.78 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Jan 24, 2017. Analyst had a consensus of $1.76. The company had revenue of $3157.00 million for the quarter, compared to analysts expectations of $3148.44 million. The company’s revenue was up 16.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.56 EPS.
Several company insiders have filed Insider transactions , on Feb 17, 2017, Yin C Becker (VP, Comm. and Public Affairs) sold 4,398 shares at $125.27 per share price. According to the SEC, on Feb 2, 2017, Roch Doliveux (director) purchased 41 shares at $123.12 per share price. On Jan 31, 2017, Louise Francesconi (director) sold 3,716 shares at $122.34 per share price, according to the Form-4 filing with the securities and exchange commission.
Stryker Corporation closed down -0.69 points or -0.53% at $128.58 with 10,05,613 shares getting traded on Monday. Post opening the session at $129, the shares hit an intraday low of $128.41 and an intraday high of $129.66 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.